Autoimmune & Rheumatology Clinical Trials Update: Week 26, 2026

Published June 26, 2026 — 5 trials covered

By Victor Lafforgue, Founder of TrialsAlert. Blog posts are AI-drafted from ClinicalTrials.gov source data and reviewed by the editorial team. See our editorial policy for details.

A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)

This study is testing baricitinib, a new oral medication, for children aged 1 to under 18 with systemic juvenile idiopathic arthritis, a rare and serious type of childhood arthritis. If successful, baricitinib could offer a simpler and effective treatment option that is easier for children to take. The trial is actively recruiting in multiple countries, with results expected after 12 weeks of treatment.

Effects of Acetyl L-Carnitine Supplementation on Clinical, Metabolic and Inflammatory Symptoms in Obese, Diabetic, Postmenopausal Women With Osteoarthritis

This trial is exploring whether acetyl L-carnitine supplements can improve symptoms and metabolic health in obese, diabetic, postmenopausal women who have osteoarthritis. If the supplement helps reduce inflammation and joint pain, it might become a new way to ease discomfort and disability in this group. The study is currently recruiting about 100 participants in Pakistan.

Mobile App-Based Yoga and Meditation in Rheumatoid Arthritis

This study is testing a mobile app that offers yoga and meditation exercises to adults with rheumatoid arthritis. The goal is to see if this approach can reduce anxiety and improve arthritis symptoms without using medication. This digital program could provide an accessible way to help people manage their condition and improve quality of life. The trial is recruiting participants in Turkey and will track results over 8 weeks.

Advancing Online Psychology Tools for Chronic Pain

This trial is developing a digital psychological program to help people with fibromyalgia and chronic pelvic pain manage their pain while waiting for specialized care. If effective, this online tool could make pain management easier to access and reduce the emotional distress often linked to chronic pain. The study aims to enroll 60 participants in Canada and is not yet recruiting.

Adapting Enhanced Supports to Improve Patient Adherence to Secondary Antibiotic Prophylaxis for Rheumatic Heart Disease

This study is testing enhanced support from community health workers to help children with rheumatic heart disease stick to their antibiotic treatment plans. Better adherence to treatment could lower the risk of complications and reduce hospital visits for affected children. The trial is recruiting 308 participants across the United States.

TrialsAlert subscribers received the full impact-classified briefing and doctor-ready report this week. Get weekly briefings at trialsalert.com.